{'fraction_non_alphanumeric': 0.018226002430133656, 'fraction_numerical': 0.001215066828675577, 'mean_word_length': 6.357142857142857, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a three‐year period

Birdshot retinochoroidopathy is a bilateral, chronic posterior uveitis of likely autoimmune aetiology characterized by multiple depigmented choroidal lesions scattered throughout the post‐equatorial retina. It has been managed with variable results using systemic immunosuppression. Herein, a case is described in which the patient, aware of the side‐effects of systemic immunosuppression, refused this form of treatment and was successfully managed over a 3‐year period with intravitreal triamcinolone. She developed the ocular complications of cataract and increased intraocular pressures, but maintained good vision while avoiding any systemic side‐effects.